Financial burden for tuberculosis patients in low- And middle-income countries: A systematic review

European Respiratory Journal

Volumn 43, Issue 6, 2014, Pages 1763-1775

  Tanimura, Tadayuki ^a   Jaramillo, Ernesto ^a   Weil, Diana ^a   Raviglione, Mario ^a   Lönnroth, Knut ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST CONTROL; COST OF ILLNESS; COST OF LIVING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HOSPITALIZATION COST; HOUSEHOLD; HUMAN; LOWEST INCOME GROUP; MIDDLE INCOME COUNTRY; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT CARE; POVERTY; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; SOCIOECONOMICS; SYSTEMATIC REVIEW; TUBERCULOSIS; ECONOMICS; FAMILY SIZE; HEALTH; HEALTH CARE COST; INCOME; RISK; STATISTICAL MODEL;

COST OF ILLNESS; FAMILY CHARACTERISTICS; GLOBAL HEALTH; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INCOME; MODELS, ECONOMIC; POVERTY; RISK; TUBERCULOSIS;

EID: 84897044389     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00193413     Document Type: Review

References (82)

1. WHO. World Health Statistics 2012. Geneva, World Health Organization, 2012.
2. WHO. Addressing Poverty in TB Control. Options for National TB Control Programmes. Geneva, World Health Organization, 2005.
3. Bates I, Fenton C, Gruber J, et al. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis 2004; 4: 267-277. (Pubitemid 38561224)
4. WHO. Global TB. Report 2013. Geneva, World Health Organization, 2013.
5. Mauch V, Bonsu F, Gyapong M, et al. Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents. Int J Tuberc Lung Dis 2013; 17: 381-387.
6. KNCV Tuberculosis Foundation, WHO, the Japan Anti-Tuberculosis Association. The Tool to Estimate Patients' Costs. Tuberculosis Coalition for Technical Assistance, US Agency for International Development, 2009.
7. WHO. World Health Report 2010: Health Systems Financing - the Path to Universal Coverage. Geneva, World Health Organization, 2010.
8. A Joint Crisis Initiative of the UN Chief Executives Board for Co-ordination on the Social Protection Floor. Geneva, The Social Protection Floor, 2009.
9. International Labour Office. World Social Security Report 2010/11: Providing Coverage in Times of Crisis and Beyond. Geneva, International Labour Organization, 2010.
10. WHO. Eliminating the Catastrophic Economic Burden of TB: Universal Health Coverage and Social Protection Opportunities. Meeting Report from a World Health Organization Consultation to Inform the Post-2015 Global TB Strategy. Geneva, World Health Organization, 2013.
11. WHO. What is Universal Coverage? www.who.int/features/qa/universal- health-coverage/en/index.html Date last updated: October 2012. Date accessed: September 2013.
12. WHO. Contributing to Health System Strengthening - Guiding Principles for National Tuberculosis Programmes. Geneva, World Health Organization, 2008.
13. WHO. The Stop TB Strategy. Geneva, World Health Organization, 2006.
14. Chatham House. Social Protection Interventions for Tuberculosis Control: The Impact, the Challenges, and the Way Forward. London, Chatham House, 2012.
15. Lönnroth K, Jaramillo E, Williams BG, et al. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240-2246.
16. Lönnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010; 375: 1814-1829.
17. Hargreaves JR, Boccia D, Evans CA, et al. The social determinants of tuberculosis: from evidence to action. Am J Public Health 2011; 101: 654-662.
18. UNCDF, UNDP. Local Government and Social Protection: Making Service Delivery Available for the Most Vulnerable. UN Capital Development Fund and United Nations Development Programme, 2011.
19. Long Q, Smith H, Zhang T, et al. Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health 2011; 11: 393.
20. Barter DM, Agboola SO, Murray MB, et al. Tuberculosis and poverty: the contribution of patient costs in sub- Saharan Africa - a systematic review. BMC Public Health 2012; 12: 980.
21. Ukwaja KN, Modebe O, Igwenyi C, et al. The economic burden of tuberculosis care for patients and households in Africa: a systematic review. Int J Tuberc Lung Dis 2012; 16: 733-739.
22. Fitzpatrick C, Floyd K. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics 2012; 30: 63-80.
23. International Labour Organization. Gross Average Nominal Monthly Wage in ILO Global Wage Database. www.ilo.org/travail/info/db/lang-en/index.htm Date accessed: July 2013.
24. World Bank. Income Share Held by Lowest 20% in the World Bank Database. http://data.worldbank.org/indicator/SI.DST.FRST.20/countries Date accessed: June 2013.
25. World Bank. Inflation, Consumer Prices (Annual %) in the World Bank Database. http://data.worldbank.org/ indicator/FP.CPI.TOTL.ZG Date accessed: July 2013.
26. UN. Purchasing Power Parities (PPP) Conversion Factor, Local Currency Unit to International Dollar. The Official United Nations Site for the MDG Indicators. http://unstats.un.org/unsd/mdg/SeriesDetail.aspx?srid=699 Updated July 2013. Date accessed: June 2013.
27. UN. National Accounts Main Aggregates Database. http://unstats.un.org/ unsd/snaama/Introduction.asp Updated December 2013. Date accessed: June 2013.
28. UN. UN Data: Exchange Rates. http://data.un.org/Data.aspx?d=IFS&f= SeriesCode%3A Date last updated: May 14, 2010. Date accessed: June 2013.
29. Ayé R, Wyss K, Abdualimova H, et al. Factors determining household expenditure for tuberculosis and coping strategies in Tajikistan. Trop Med Int Health 2011; 16: 307-313.
30. Muniyandi M, Ramachandran R, Balasubramanian R. Costs to patients with tuberculosis treated under DOTS programme. Indian J Tuberc 2005; 52: 188-196. (Pubitemid 43018956)
31. Rajeswari R, Balasubramanian R, Muniyandi M, et al. Socio-economic impact of tuberculosis on patients and family in India. Int J Tuberc Lung Dis 1999; 3: 869-877. (Pubitemid 29488039)
32. Karki DK, Mirzoev TN, Green AT, et al. Costs of a successful public-private partnership for TB control in an urbansetting in Nepal. BMC Public Health 2007; 7: 84.
33. Xu B, Dong HJ, Zhao Q, et al. DOTS in China - removing barriers or moving barriers? Health Policy Plan 2006; 21: 365-372. (Pubitemid 44594423)
34. Kemp JR, Mann G, Simwaka BN, et al. Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe. Bull World Health Organ 2007; 85: 580-585. (Pubitemid 47333815)
35. Needham DM, Godfrey-Faussett P, Foster SD. Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis 1998; 2: 811-817. (Pubitemid 28461996)
36. Mesfin MM, Newell JN, Madeley RJ, et al. Cost implications of delays to tuberculosis diagnosis among pulmonary tuberculosis patients in Ethiopia. BMC Public Health 2010; 10: 173.
37. Jacquet V, Morose W, Schwartzman K, et al. Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti. BMC Public Health 2006; 6: 209.
38. Lönnroth K, Aung T, Maung W, et al. Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection. Health Policy Plan 2007; 22: 156-166. (Pubitemid 47355780)
39. Gibson N, Boillot F, Jalloh H. The cost of tuberculosis to patients in Sierra Leone's war zone. Int J Tuberc Lung Dis 1998; 2: 726-731. (Pubitemid 28429722)
40. Kamolratanakul P, Sawert H, Kongsin S, et al. Economic impact of tuberculosis at the household level. Int J Tuberc Lung Dis 1999; 3: 596-602. (Pubitemid 29336576)
41. Wyss K, Kilima P, Lorenz N. Costs of tuberculosis for households and health care providers in Dar es Salaam, Tanzania. Trop Med Int Health 2001; 6: 60-68. (Pubitemid 32221301)
42. Saunderson PR. An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda. Soc Sci Med 1995; 40: 1203-1212.
43. Sinanovic E, Floyd K, Dudley L, et al. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis 2003; 7: S56-S62. (Pubitemid 37162932)
44. Jackson S, Sleigh AC, Wang GJ, et al. Poverty and the economic effects of TB in rural China. Int J Tuberc Lung Dis 2006; 10: 1104-1110. (Pubitemid 44519347)
45. Pantoja A, Lönnroth K, Lal SS, et al. Economic evaluation of PPM-DOTS in Bangalore, south India. Part II: cost and cost-effectiveness of intensified efforts. Int J Tuberc Lung Dis 2009; 13: 705-712.
46. Ananthakrishnan R, Muniyandi M, Jeyaraj A, et al. Expenditure pattern for TB treatment among patients registered in an urban government DOTS program in Chennai City, South India. Tuberc Res Treat 2012; 2012: 747924.
47. Othman GQ, Ibrahim MI, Raja'a YA. Costs associated with tuberculosis diagnosis and treatment in Yemen for patients and public health services. East Mediterr Health J 2012; 18: 393-398.
48. Pichenda K, Nakamura K, Morita A, et al. Non-hospital DOT and early diagnosis of tuberculosis reduce costs while achieving treatment success. Int J Tuberc Lung Dis 2012; 16: 828-834.
49. Ayé R, Wyss K, Abdualimova H, et al. Household costs of illness during different phases of tuberculosis treatment in Central Asia: a patient survey in Tajikistan. BMC Public Health 2010; 10: 18.
50. Steffen R, Menzies D, Oxlade O, et al. Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil. PLoS One 2010; 5: e14014.
51. Rouzier VA, Oxlade O, Verduga R, et al. Patient and family costs associated with tuberculosis, including multidrugresistant tuberculosis, in Ecuador. Int J Tuberc Lung Dis 2010; 14: 1316-1322.
52. John KR, Daley P, Kincler N, et al. Costs incurred by patients with pulmonary tuberculosis in rural India. Int J Tuberc Lung Dis 2009; 13: 1281-1287.
53. Muniyandi M, Ramachandran R, Balasubramanian R, et al. Socio-economic dimensions of tuberculosis control: review of studies over two decades from Tuberculosis Research Center. J Commun Dis 2006; 38: 204-215.
54. Elamin EI, Ibrahim MI, Sulaiman SA, et al. Cost of illness of tuberculosis in Penang, Malaysia. Pharm World Sci 2008; 30: 281-286.
55. Mahendradhata Y, Probandari A, Ahmad RA, et al. The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia. Am J Trop Med Hyg 2010; 82: 1131-1139.
56. Sinanovic E, Kumaranayake L. Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa. Cost Eff Resour Alloc 2006; 4: 11.
57. Vassall A, Seme A, Compernolle P, et al. Patient costs of accessing collaborative tuberculosis and human immunodeficiency virus interventions in Ethiopia. Int J Tuberc Lung Dis 2010; 14: 604-610.
58. Costa JG, Santos AC, Rodrigues LC, et al. Tuberculosis in Salvador, Brazil: costs to health system and families. Rev Saude Publica 2005; 39: 122-128. (Pubitemid 40439631)
59. El-Sony AI. The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan. Health Policy 2006; 75: 272-279. (Pubitemid 43042361)
60. Khan MA, Walley JD, Witter SN, et al. Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Directly Observed Treatment. Health Policy Plan 2002; 17: 178-186. (Pubitemid 34587121)
61. Umar NA, Fordham R, Abubakar I, et al. The indirect cost due to pulmonary tuberculosis in patients receiving treatment in Bauchi State - Nigeria. Cost Eff Resour Alloc 2012; 10: 6.
62. Vassall A, Bagdadi S, Bashour H, et al. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria. Int J Tuberc Lung Dis 2002; 6: 1083-1090. (Pubitemid 36054962)
63. Meng Q, Li R, Cheng G, et al. Provision and financial burden of TB services in a financially decentralized system: a case study from Shandong, China. Int J Health Plann Manage 2004; 19: Suppl. 1, S45-S62. (Pubitemid 40201956)
64. Zhan S, Wang L, Yin A, et al. Revenue-driven in TB control - three cases in China. Int J Health Plann Manage 2004; 19: Suppl. 1, S63-S78. (Pubitemid 40201957)
65. Ray TK, Sharma N, Singh MM, et al. Economic burden of tuberculosis in patients attending DOT centres in Delhi. J Commun Dis 2005; 37: 93-98. (Pubitemid 43652568)
66. Datiko DG, Lindtjørn B. Cost and cost-effectiveness of smear-positive tuberculosis treatment by Health Extension Workers in Southern Ethiopia: a community randomized trial. PLoS One 2010; 5: e9158.
67. Croft RA, Croft RP. Expenditure and loss of income incurred by tuberculosis patients before reaching effective treatment in Bangladesh. Int J Tuberc Lung Dis 1998; 2: 252-254. (Pubitemid 28123526)
68. Okello D, Floyd K, Adatu F, et al. Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis 2003; 7: S72-S79. (Pubitemid 37162934)
69. Wandwalo E, Robberstad B, Morkve O. Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Eff Resour Alloc 2005; 3: 6.
70. Prado TN, Wada N, Guidoni LM, et al. Cost-effectiveness of community health worker versus home-based guardians for directly observed treatment of tuberculosis in Vitória, Espírito Santo State, Brazil. Cad Saude Publica 2011; 27: 944-952.
71. Mirzoev TN, Baral SC, Karki DK, et al. Community-based DOTS and family member DOTS for TB control in Nepal: costs and cost-effectiveness. Cost Eff Resour Alloc 2008; 6: 20.
72. Jacobs B, Clowes C, Wares F, et al. Cost-effectiveness analysis of the Russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia. Int J Tuberc Lung Dis 2002; 6: 396-405. (Pubitemid 34492163)
73. Mauch V, Woods N, Kirubi B, et al. Assessing access barriers to tuberculosis care with the tool to estimate patients' costs: pilot results from two districts in Kenya. BMC Public Health 2011; 11: 43.
74. Laokri S, Drabo MK, Weil O, et al. Patients are paying too much for tuberculosis: a direct cost-burden evaluation in Burkina Faso. PLoS One 2013; 8: e56752.
75. Umar NA, Abubakar I, Fordham R, et al. Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria. Int J Tuberc Lung Dis 2012; 16: 835-840.
76. Aspler A, Menzies D, Oxlade O, et al. Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. Int J Tuberc Lung Dis 2008; 12: 928-935.
77. Liu X, Thomson R, Gong Y, et al. How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives. Trop Med Int Health 2007; 12: 1464-1471. (Pubitemid 350212712)
78. Rockefeller Foundation, Save the Children, UNICEF, WHO. Universal Health Coverage: A Commitment to Close the Gap. London, Save the Children, 2013.
79. Floyd K, Arora VK, Murthy KJR, et al. Cost and cost-effectiveness of public and private sector collaboration in tuberculosis control: evidence from India. Bull World Health Organ 2006; 84: 437-445. (Pubitemid 43845443)
80. WHO. WHO Guide to Identifying the Economic Consequences of Disease and Injury. Geneva, World Health Organization, 2009.
81. Wagstaff A, Bilger M, Sajaia Z, et al. Health Equity and Financial Protection. Washington, The International Bank for Reconstruction and Development/The World Bank, 2011.
82. Ranson MK. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull World Health Organ 2002; 80: 613-621.